Home Wealth  Money Gilead Pays Up For Pharmasset

Gilead Pays Up For Pharmasset

Posted: Nov. 22nd, 2011  |  By Forbes

powered by Forbes

RSS Syndicated News Email a Friend Suggest an Article Share Visit Website

Gilead Sciences has agreed to acquire Pharmasset for $137 per share in cash.

The transaction values Pharmasset (nasdaq: VRUS - news - people ) at $11 billion, and is expected to be completed in the first quarter of 2012.

Pharmasset's board has approved the transaction, and Gilead (nasdaq: GILD - news - people ) said it will be accretive to earnings beginning in 2015.

Gilead said the acquisition represents an important and exciting opportunity to accelerate its effort to change the treatment paradigm for hepatitis C with all-oral regimens.

Pharmasset has three clinical-stage candidates for the treatment of chronic hepatitis C virus.

Keep an eye on shares of Regeneron Pharmaceuticals (nasdaq: REGN - news - people ) today as well.

The company said late Friday the US Food and Drug Administration has approved its EYLEA injection for the treatment of patients with neovascular age-related macular degeneration.

The treatment was approved at a dose of 2 milligrams every four weeks for the first 12 weeks, followed by 2 milligrams every eight weeks.

Market News Video produces and distributes online videos about stocks and investing.

Share on Facebook Share
See Next Article
Need to Get Away?
Top 10 Business Hotels
Who says you canít mix business with pleasure?
Read More
More Articles from Forbes.com

Quick Links
Real Estate
Luxury Travel
Search Real Estate
Find Your Dream Home
Search for homes by
State, Country or Style.
Event Calendar
Current News & Features
The $300k Tesla Model X is Here and It Is Everything We Have Always Wanted From an SUV
Kate Hudson Plays Naughty and Nice in the 2016 Annual Campari Calendar
Make Your Vintage Records Sound Like $30k With the SG1.2 Turntable
Meet the Fastest SUV in the World, the $300k Bentley Bentayga
David Beckham Plays Biker Outlaw in Belstaff's Circus Film-Inspired Short
DAMEN's SeaXplorer is Part Luxury Superyacht, Part Exploration Beast
The 2-in-1 Soothing Power of the Dyson Pure Cool Air Purifying Fan
Can the Lumo Lift Wearable Gadget Cure Bad Posture? We Put it to the Test
Lupita Nyong'o Answers 73 Rapid Fire Questions About Star Wars, Growing Up in Kenya & Her Inspirations
Top 5 Priciest Classic Foods for the Sophisticated Palate
See the complete list
Featured Photo Gallery
See the complete list